Table 3.
Effect of DAZZEON αSleep® on vascular age and level of arteriosclerosis before and after the 2-week intervention and before and after the 30 min coverage.
| Arteriosclerosis Examination Instruction |
Vascular Age (Years) | Right baPWV (cm/s) | Left baPWV (cm/s) | |||
|---|---|---|---|---|---|---|
| Placebo | αSleep® | Placebo | αSleep® | Placebo | αSleep® | |
| Day 0 | ||||||
| Before | 55 ± 11 a | 59 ± 11 a | 1324 ± 206 a | 1313 ± 263 a | 1297 ± 234 a | 1359 ± 230 a |
| After | 55 ± 11 a | 58 ± 9 a | 1306 ± 208 a | 1285 ± 219 a | 1290 ± 232 a | 1302 ± 231 a |
| Day 14 | ||||||
| Before | 55 ± 11 a | 59 ± 11 a | 1311 ± 224 a | 1323 ± 212 a | 1267 ± 127 a | 1363 ± 251 a |
| After | 56 ± 12 a | 58 ± 10 a | 1263 ± 211 b | 1261 ± 195 a | 1343 ± 194 a | 1234 ± 112 a |
| Group (A) | F(7, 104) = 0.823, p = 0.366 | F(7, 104) = 0.008, p = 0.930 | F(7, 104) = 0.180, p = 0.672 | |||
| Time (B) | F(7, 104) = 0.116, p = 0.734 | F(7, 104) = 0.035, p = 0.851 | F(7, 104) = 0.144, p = 0.705 | |||
| Measurement (C) | F(7, 104) = 0.105, p = 0.746 | F(7, 104) = 0.078, p = 0.781 | F(7, 104) = 0.858, p = 0.356 | |||
| (A) × (B) | F(7, 104) = 0.020, p = 0.875 | F(7, 104) = 0.729, p = 0.395 | F(7, 104) = 0.109, p = 0.741 | |||
| (A) × (C) | F(7, 104) = 0.153, p = 0.942 | F(7, 104) = 0.375, p = 0.541 | F(7, 104) = 0.037, p = 0.848 | |||
| (B) × (C) | F(7, 104) = 0.116, p = 0.734 | F(7, 104) = 0.103, p = 0.521 | F(7, 104) = 0.114, p = 0.736 | |||
| (A) × (B) × (C) | F(7, 104) < 0.001, p = 0.993 | F(7, 104) = 0.244, p = 0.622 | F(7, 104) = 0.072, p = 0.789 | |||
Data are presented as mean ± SD. Different superscript letters (a, b) indicate significant difference among groups at the same time point (p < 0.05). baPWV, brachial–ankle pulse wave velocity.